539 filings
Page 4 of 27
8-K
nbgwr9mn9ppnt2cxv2
5 Nov 21
Submission of Matters to a Vote of Security Holders
4:33pm
8-K
94h6e4pniat21z4hwovz
6 Oct 21
Departure of Directors or Certain Officers
8:30am
8-K
g8lafy
6 Aug 21
Other Events
5:02pm
8-K
m16bnstrp8zb
22 Jul 21
JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients
9:46am
8-K
bqls6kizvkj
23 Jun 21
Company Fully Prepared to Commence Phase 2b Trials of JAN101 for Peripheral Artery Disease (PAD) as Soon as New Protocol is Approved by the FDA
10:14am
8-K
ycf2t4 eh
22 Jun 21
JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing
9:46am
8-K
sa8hurntfbbv78rdug
15 Jun 21
JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board
10:16am
8-K
dk6broxod9iaz47 34z3
8 Jun 21
Other Events
9:45am
8-K
trorr5y
16 Apr 21
Amendments to Articles of Incorporation or Bylaws
5:00pm
S-8
p2cps11l3 zynrj3uro
30 Mar 21
Registration of securities for employees
5:09pm
8-K
ygsdaw5
25 Feb 21
JanOne Announces Definitive Agreement to Sell its Legacy Recycling Business for $25 Million
4:05pm
8-K
qll1f
2 Feb 21
JanOne Announces Closing of $6.0 Million Common Stock Offering
5:27pm
424B5
rip g35on
2 Feb 21
Prospectus supplement for primary offering
1:30pm
8-K
w09oos
29 Jan 21
JanOne Prices $6.0 Million Common Stock Offering
9:08am
EFFECT
xykh 7htqlb
30 Dec 20
Notice of effectiveness
12:15am